Brain Monitoring Market to Reach USD 8.65 Billion at 6.50 % CAGR, By 2030: MRFR

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Brain Monitoring Devices Market Research ReportMarket SegmentationThe global brain monitoring market has been segmented based on product & service, type, application and end-user.Based on type, the global brain monitoring market has been segmented into intracranial pressure (ICP) monitoring, electroencephalography (EEG) monitoring, transcranial doppler (TCD) monitoring, magnetoencephalography (MEG) monitoring and electromyography (EMG) monitoring. The EEG monitoring segment holds the largest market share and is also expected to be the fastest-growing segment during the forecast period.The global market for brain monitoring has been split into product and service categories. The product category is subdivided into devices and accessories. The services segment is subdivided into managed services and professional services.The global market for brain monitoring has been divided based on application into addiction, sleep disorder, attention-deficit disorder, neurological disorder, and monitoring. The monitoring segment holds the biggest market share and is anticipated to increase at the highest rate throughout the forecast period.

Regional Analysis

The global market for brain monitoring has been analyzed in terms of five regions: North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.During the projected period, North America is anticipated to dominate the worldwide brain monitoring market. This growth can be attributed to the presence of significant number of market players in the region and their presence in research and development activities. In addition, improving healthcare infrastructure, rising healthcare spending and technological advancements are fuelling the growth of the market in the region.The Asia-Pacific brain monitoring market is anticipated to be the fastest-growing region over the forecast period. This growth can be attributed to the rapid growth of healthcare industry, surge in the number of hospitals and development of pediatric care services in the region.Over the forecast period, the market for brain monitoring in Europe is anticipated to exhibit somewhat stable growth. The market in Europe is also expected to benefit from several government initiatives such as Collaborative Project on Clinical Brain Monitoring in Europe and European Imaging in Parkinson’s Disease (EIPD).Competitive LandscapeThe major players operating in the global brain monitoring market are Avadel Pharmaceuticals plc (Republic of Ireland), Natus Medical Incorporated (US), Nihon Kohden Corporation (Japan), SIGMA Medizin-Technik GmbH & Co KG (Germany), Compumedics Limited (Australia), Advanced Brain Monitoring (US), CAS Medical Systems, Inc. (US), Medtronic plc (Republic of Ireland), NeuroWave Systems, Inc. (US) and uralytics GmbH (Germany).Industry/Innovation/Related NewsJune 2019 – The FDA approved a new neuromonitoring device by Medtronic plc for patients undergoing vertebral augmentation procedures for treatment of spinal abnormalities. The device is the first non-bone-conducted acoustic neural monitoring system cleared by FDA.Market Segmentation:Global Brain Monitoring Market, By Product & Service

•  Product


•  Devices


•  Accessories


•  Services


•  Managed


•  Professional

Global Brain Monitoring Market, By Type

•  Intracranial Pressure (ICP) Monitoring


•  Electroencephalography (EEG) Monitoring


•  Transcranial Doppler (TCD) Monitoring


•  Magnetoencephalography (MEG) Monitoring


•  Electromyography (EMG) Monitoring

Global Brain Monitoring Market, By Application

•  Addiction


•  Sleep Disorder


•  Attention Deficit Disorder


•  Neurological Disorder


•  Monitoring

Global Brain Monitoring Market, By End-User

•  Hospitals


•  Clinics


•  Diagnostic Centres


•  Home Care Setting

Global Brain Monitoring Market, By Region

•  North America


•  Europe


•  Asia Pacific


•  Latin America


•  Middle East & Africa

Key Players

•  Avadel Pharmaceuticals plc (Republic of Ireland)


•  Natus Medical Incorporated (US)


•  Nihon Kohden Corporation (Japan)


•  SIGMA Medizin-Technik GmbH & Co KG (Germany)


•  Compumedics Limited (Australia)


•  Advanced Brain Monitoring (US)


•  CAS Medical Systems, Inc. (US)


•  Medtronic plc (Republic of Ireland)


•  NeuroWave Systems, Inc. (US)


•  uralytics GmbH (Germany)

Research MethodologyMarket Research Future (MRFR) employs advanced secondary sources such as company annual reports, press releases, government documents, trade associations, industry journals, financial reports and white papers. MRFR’s primary research also involves extensive interviews and studies with market participants, vendors and stakeholders for data validation.The market estimates and forecasts are obtained through extensive secondary research, primary studies and in-house data analysis. The segments are analyzed via both top-down and bottom-up approaches. Extensive validation is carried out at every stage to ensure accurate sizing, scope and data representation of the global brain monitoring market.Market numbers are estimated using the bottom-up approach, wherein market data is derived from the key players’ revenue and offered in the global brain monitoring market. The market size is then cross-validated with secondary sources and primary research to validate the market estimates.Market numbers for different segments are estimated using the bottom-up approach, wherein market data for each segment is derived from the bottom level and validated with respective secondary sources and primary research. The estimation is also done using various forecasting tools in matrices to arrive at the market numbers. Currency conversions used for the market calculations are based on the prevailing rate as of the date of forecast.Market ForecastThe brain monitoring market is anticipated to reach a noteworthy market size of USD 5.30 billion at a 7.2% CAGR over the forecast period (2019-2025). Factors such as the growing inclination towards preventive healthcare, development of advanced monitoring techniques, increasing R&D activities in the field of neuroscience and increasing healthcare expenditure are projected to drive the growth of the market.The global brain monitoring market is further segmented into North America, Europe, Asia-Pacific, Latin America and the Middle East & Africa.North America holds the largest share in the global brain monitoring market. This growth can be attributed to the presence of significant number of market players in the region and their presence in research and development activities. In addition, improving healthcare infrastructure and rising healthcare spending are helping the regional market grow.The Asia-Pacific brain monitoring market is estimated to be the fastest-growing region during the forecast period. This growth can be attributed to the rapid growth of healthcare industry, surge in the number of hospitals and development of pediatric care services in the region.The Europe brain monitoring market is anticipated to witness moderately stable growth during the forecast period. The market in Europe is also expected to benefit from various government initiatives such as Collaborative Project on Clinical Brain Monitoring in Europe and European Imaging in Parkinson’s Disease (EIPD).The report also includes detailed profiles of the key players in the market such as Avadel Pharmaceuticals plc (Republic of Ireland), Natus Medical Incorporated (US), Nihon Kohden Corporation (Japan), SIGMA Medizin-Technik GmbH & Co KG (Germany), Compumedics Limited (Australia), Advanced Brain Monitoring (US), CAS Medical Systems, Inc. (US), Medtronic